Lyme Treatment: Why “Start Low, Go Slow” Can Make the Difference
Side effects often limit treatment success
Lower doses can improve tolerance
Flexible dosing helps patients stay on therapy
When treating Lyme disease, one of the biggest challenges is not just choosing the right antibiotic—it’s making sure the patient can tolerate it. :contentReference[oaicite:0]{index=0}
In my experience, a flexible, common-sense approach to dosing often determines whether treatment succeeds or fails—especially for patients who struggle with side effects or sensitivities.
When Standard Doses Don’t Work
Some patients stop treatment early because of side effects.
I once treated a patient who had been reluctant to restart antibiotics after a difficult initial experience. By beginning with a lower dose, he was able to tolerate treatment and complete therapy—something that hadn’t been possible before.
This scenario is more common than many realize.
When the Gut Gets in the Way
Many patients have underlying gastrointestinal issues that make antibiotic therapy difficult, including:
- Gastroparesis
- Irritable bowel syndrome (IBS)
- Diarrhea or constipation
- Candida or yeast overgrowth
Others experience Herxheimer reactions, a temporary worsening of symptoms caused by bacterial die-off.
This reaction can be overwhelming—particularly for patients already dealing with fatigue, pain, and brain fog.
Some patients also have difficulty swallowing pills or tolerating liquid formulations, further complicating treatment.
Ruling Out Other Causes of Intolerance
Before assuming antibiotics are the primary issue, it’s important to evaluate for underlying conditions.
- A gastroenterologist can assess for structural or motility disorders
- Other specialists may evaluate for autonomic dysfunction, which can impair digestion and absorption
Identifying these factors allows for a more effective and tolerable treatment plan.
Weighing Risks and Benefits
Some patients have tried dietary changes or alternative therapies but remain ill.
At that point, the decision becomes whether to retry antibiotics.
I help patients weigh:
- The risks of antibiotic side effects
- The risks of untreated or undertreated infection
Some choose not to pursue antibiotics, which I respect. In these cases, I still recommend reducing alcohol and processed sugars, which may worsen inflammation and gut symptoms.
What I Do Differently: Start Low, Go Slow
For patients willing to proceed, I use a “start low, go slow” approach.
This means beginning at lower doses and gradually increasing based on tolerance.
- Doxycycline: start at 25–50 mg once daily (vs. 100 mg twice daily)
- Cefuroxime: reduce from 500 mg twice daily to 250 mg twice daily
- Azithromycin: 250 mg every other or third day
- Atovaquone: start as low as 62.5–250 mg twice daily
In some cases, once-daily dosing is used initially.
Lower doses can still be effective—and far better tolerated.
Limitations of IV Therapy
Intravenous ceftriaxone is sometimes used, but it is not always ideal.
Although it bypasses the gut initially, it still circulates through the gastrointestinal system and may trigger similar side effects.
It is also not effective for common co-infections such as Babesia, which are discussed in our coinfections guide.
Follow-Up Matters
I typically follow up within one month of starting treatment.
This allows me to assess:
- Tolerance of the current dose
- Clinical response
- Need for adjustments
Patients are encouraged to report problems early so we can adjust before treatment fails.
The Bottom Line
Lyme disease treatment is not one-size-fits-all.
A “start low, go slow” approach can help patients tolerate therapy, stay on treatment, and improve outcomes.
Start here: Lyme disease treatment options
Struggling with Lyme treatment side effects? You’re not alone—there are ways to adjust treatment so it works for you.
Dr. Daniel Cameron, MD, MPH
Lyme disease clinician with over 30 years of experience and past president of ILADS.
Symptoms • Testing • Coinfections • Recovery • Pediatric • Prevention
